The FDA rejected two new products…
The FDA rejected two new products from AbbVie and Grace [...]
The FDA rejected two new products from AbbVie and Grace [...]
After a series of setbacks for Sanofi’s tolebrutinib, the French [...]
An established sales force and payer authorization criteria will fuel [...]
Daiichi Sankyo has postponed its annual report by two weeks, [...]
Roche’s Genentech unit is launching a new multimedia campaign aimed [...]
During Pfizer’s right-sizing push after the COVID-19 pandemic, the company’s [...]
Merck & Co. unveiled the much-anticipated first look at its [...]
Patients’ confidence in their ability to find answers about health [...]
Pfizer is kicking off the next stage of its cancer [...]
Travis Smith was a very serious baby. Born completely unable [...]